About Us

The development of new drug and therapies suffer from high costs, slow progress and a high failure rate. Our team is made up of highly engaged and collaborative researchers dedicated to improve the safety, efficiency and success rate of clinical research and drug development by developing and implementing innovative adaptive clinical trial designs.

PrincipAL Investigator

Dr. Ying Yuan

Dr. Ying Yuan

Professor

The University of Texas MD Anderson Cancer Center

Dr. Jack Lee

Dr. Jack Lee

Professor

The University of Texas MD Anderson Cancer Center

 
 

Team member

Chunyan

Dr. Chunyan Cai

Assistant Professor

The University of Texas Health Science Center at Houston

Mike

Yiyi Chu

Ph.D. Student

The University of Texas Health Science Center at Houston

Rongji

Rongji Mu

Visiting Ph.D. Student

East China Normal University (Shanghai, China)

Tom

Tom Murray

Postdoc

The University of Texas MD Anderson Cancer Center

Haitao

Haitao Pan

Ph.D. Student

The University of Texas MD Anderson Cancer Center

Yong

Dr. Yong Zang

Assistant Professor

School of Medicine, Indiana University
.

Heng

Heng Zhou

Ph.D. Student

The University of Texas MD Anderson Cancer Center

Yanhong

Yanhong Zhou

Ph.D. Student

The University of Texas MD Anderson Cancer Center